Health committee  It's a provincial-territorial initiative.

Health committee  Just as a clarification, in terms of what JODR is looking at within its scope, it's essentially drugs for active treatment of cancer, both oral and intravenous drugs, for new chemical entities and new indications for the older drugs. The--

Health committee  For the oncology indication, it would go through JODR if it was for cancer treatment.

Health committee  It may.

Health committee  Nexavar is currently under reconsideration through the Ontario process.

Health committee  I'll answer the first question on the relationship between the Canadian Partnership Against Cancer and the JODR. It's the intent of the JODR process in phase three, which started some time in the summer, to start to look for synergies and linkages with national initiatives such a

Health committee  Thank you very much for the invitation to make a presentation to the Standing Committee on Health. I'm participating today as a representative from Cancer Care Ontario, and I currently hold the position of director of provincial drug reimbursement programs at Cancer Care Ontario.

Health committee  In Ontario, cancer drugs are funded through a variety of mechanisms. Drugs that are given in the hospital intravenously are primarily funded through our provincial IV cancer formulary, called the new drug funding program, a program that's administered by Cancer Care Ontario on be